Document is current
Any future updates will be listed below
-
Authors
Notara, M.
Behboudifard, S.
Kluth, M. A.
Maßlo, C.
Ganss, C.
Frank, M. H. https://orcid.org/0000-0002-1312-0488
Schumacher, B. https://orcid.org/0000-0001-6097-5238
Cursiefen, C.
- License Information
-
More Information
Article History
Received: 10 August 2017
Accepted: 16 July 2018
First Online: 22 August 2018
Competing Interests
: Maria Notara: Supported by a Johnson and Johnson Vision Investigator-Initiated Study grant to carry out this study. Christoph Ganss: CEO and shareholder of TICEBA GmbH; CEO of RHEACELL GmbH & Co. KG. Andreas Kluth: CSO of TICEBA GmbH; CSO of RHEACELL GmbH & Co. KG. Christoph Maßlo: Project coordinator of RHEACELL GmbH & Co. KG. M.H.F. is inventor or co-inventor of US and international patents assigned to Brigham and Women’s Hospital and/or Boston Children’s Hospital, Boston, MA, and licensed to TICEBA GmbH (Heidelberg, Germany) and RHEACELL GmbH & Co. KG (Heidelberg, Germany). M.H.F. serves as a scientific advisor to TICEBA GmbH and RHEACELL GmbH & Co. KG. and participates in corporate sponsored research collaborations with RHEACELL GmbH & Co. KG.
